Inactivation of Burkholderia cepacia Complex Phage KS9 gp41 Identifies the Phage Repressor and Generates Lytic Virions

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Virology

• Publication date

  2009-11-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.01843-09PMID 19939932PMCID PMC2812329
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Experimental Bacteriophage Therapy Increases Survival of Galleria mellonella Larvae Infected with Clinically Relevant Strains of the Burkholderia cepacia Complex

  2009influential reference
• Biosynthesis and Structure of the Burkholderia cenocepacia K56-2 Lipopolysaccharide Core Oligosaccharide

  2009cited by this paper
• Development of Galleria mellonella as an Alternative Infection Model for the Burkholderia cepacia Complex

  2008influential reference
• The final step in the phage infection cycle: the Rz and Rz1 lysis proteins link the inner and outer membranes

  2008cited by this paper
• OCTOPUS: improving topology prediction by two-track ANN-based preference scores and an extended topological grammar

  2008cited by this paper
• Bacteriophages: Biology and Applications

  2007cited by this paper
• Bacteriophages: an appraisal of their role in the treatment of bacterial infections.

  2007cited by this paper
• Role of phages in the pathogenesis of Burkholderia, or 'Where are the toxin genes in Burkholderia phages?'.

  2007cited by this paper
• Phage Therapy - Everything Old is New Again.

  2006cited by this paper
• A Complete Lipopolysaccharide Inner Core Oligosaccharide Is Required for Resistance of Burkholderia cenocepacia to Antimicrobial Peptides and Bacterial Survival In Vivo

  2006cited by this paper
• GTP Cyclohydrolase II Structure and Mechanism*

  2005cited by this paper
• Isolation and characterization of bacteriophages of the Burkholderia cepacia complex.

  2005influential reference
• Molecular mechanisms of phage infection

  2005cited by this paper
• ACT: the Artemis comparison tool

  2005cited by this paper
• Homing endonuclease genes: the rise and fall and rise again of a selfish element.

  2004cited by this paper
• Burkholderia cenocepacia phage BcepMu and a family of Mu-like phages encoding potential pathogenesis factors.

  2004cited by this paper
• The Use of Phage Lytic Enzymes to Control Bacterial Infections

  2004cited by this paper
• Conserved translational frameshift in dsDNA bacteriophage tail assembly genes.

  2004influential reference
• Genomic Diversity of Burkholderia pseudomallei Clinical Isolates: Subtractive Hybridization Reveals a Burkholderia mallei-Specific Prophage in B. pseudomallei 1026b

  2004cited by this paper
• The prospect for bacteriophage therapy in Western medicine

  2003influential reference
• Prediction of lipoprotein signal peptides in Gram‐negative bacteria

  2003cited by this paper
• Mfold web server for nucleic acid folding and hybridization prediction

  2003cited by this paper
• Bacteriophage T4 Genome

  2003cited by this paper
• Prophages and bacterial genomics: what have we learned so far?

  2003influential reference
• Development of a novel method of lytic phage delivery by use of a bacteriophage P22 site-specific recombination system.

  2003cited by this paper
• Updated Version of the Burkholderia cepacia Complex Experimental Strain Panel

  2003cited by this paper
• Burkholderia thailandensis E125 Harbors a Temperate Bacteriophage Specific for Burkholderia mallei

  2002influential reference
• Epidemiology of Burkholderia cepacia Complex in Patients with Cystic Fibrosis, Canada

  2002cited by this paper
• Common themes among bacteriophage-encoded virulence factors and diversity among the bacteriophages involved.

  2002cited by this paper
• Bacteriophage Therapy Rescues Mice Bacteremic from a Clinical Isolate of Vancomycin-Resistant Enterococcus faecium

  2002cited by this paper
• Exacerbations of chronic obstructive pulmonary disease

  2002cited by this paper
• Frequency of morphological phage descriptions in the year 2000

  2001cited by this paper
• Understanding bacteriophage therapy as a density-dependent kinetic process.

  2001cited by this paper
• Burkholderia, a Genus Rich in Plant-Associated Nitrogen Fixers with Wide Environmental and Geographic Distribution

  2001cited by this paper
• Diagnostically and Experimentally Useful Panel of Strains from the Burkholderia cepacia Complex

  2000cited by this paper
• Phages will out: strategies of host cell lysis.

  2000cited by this paper
• Improved Antibiotic-Resistance Cassettes Through Restriction Site Elimination Using Pfu DNA Polymerase PCR

  1999cited by this paper
• GeneMark.hmm: new solutions for gene finding.

  1998influential reference
• Improved antibiotic-resistance cassettes through restriction site elimination using Pfu DNA polymerase PCR.

  1998cited by this paper
• Plasposons: Modular Self-Cloning Minitransposon Derivatives for Rapid Genetic Analysis of Gram-Negative Bacterial Genomes

  1998cited by this paper
• Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.

  1997cited by this paper
• Molecular genetics of bacteria

  1997cited by this paper
• Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis.

  1993cited by this paper
• Phenol and trichloroethylene degradation by Pseudomonas cepacia G4: kinetics and interactions between substrates

  1990cited by this paper
• Molecular Genetics of Bacteria

  1989cited by this paper
• Molecular biology (2nd edn): by David Freifelder, Jones & Bartlett Publishers, 1987. £19.95 (xxiv + 834 pages) ISBN 0 86720 069 3

  1987cited by this paper
• Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.

  1984cited by this paper
• Molecular genetics of bacteriophage P22

  1978cited by this paper
• Molecular genetics of bacteriophage P22.

  1978cited by this paper
• Transport of vitamin B12 in tonB mutants of Escherichia coli

  1976cited by this paper
• Association of Pseudomonas cepacia with chronic granulomatous disease

  1975cited by this paper
• Sour skin, a bacterial rot of Onion bulbs.

  1950cited by this paper

• Synergy between ciprofloxacin and temperate phages overcomes therapeutic limitations caused by lysogen formation

  2025cites this paper
• Burkholderia Phages and Control of Burkholderia-Associated Human, Animal, and Plant Diseases

  2025cites this paper
• Characterization and Comparative Genomic Analysis of vB_BceM_CEP1: A Novel Temperate Bacteriophage Infecting Burkholderia cepacia Complex

  2024cites this paper
• Harnessing the diversity of Burkholderia spp. prophages for therapeutic potential

  2024cites this paper
• Phage therapy to treat cystic fibrosis Burkholderia cepacia complex lung infections: perspectives and challenges

  2024cites this paper
• Genomic and taxonomic evaluation of 38 Treponema prophage sequences

  2024cites this paper
• Harnessing the Diversity of Burkholderia spp. Prophages for Therapeutic Potential

  2024cites this paper
• Bacteriophage steering of Burkholderia cenocepacia toward reduced virulence and increased antibiotic sensitivity

  2023cites this paper
• Synergistic Interactions among Burkholderia cepacia Complex-Targeting Phages Reveal a Novel Therapeutic Role for Lysogenization-Capable Phages

  2023cites this paper
• Phage-inspired strategies to combat antibacterial resistance

  2023cites this paper
• Phage Milagro: a platform for engineering a broad host range virulent phage for Burkholderia

  2023cites this paper
• The long and sinuous road to phage-based therapy of Clostridioides difficile infections

  2023cites this paper
• The Isolation and Characterization of a Broad Host Range Bcep22-like Podovirus JC1

  2022cites this paper
• Harnessing the diversity of Burkholderia spp. prophages for therapeutic potential by

  2022cites this paper
• Advances in Phage Therapy: Targeting the Burkholderia cepacia Complex

  2021cites this paper
• Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future

  2021cites this paper
• Characterization of Novel Broad-Host-Range Bacteriophage DLP3 Specific to Stenotrophomonas maltophilia as a Potential Therapeutic Agent

  2020cites this paper
• Use of Greater Wax Moth Larvae (Galleria mellonella) as an Alternative Animal Infection Model for Analysis of Bacterial Pathogenesis.

  2019cites this paper
• Genetically modified bacteriophages in applied microbiology

  2016cites this paper
• The isolation and characterization of two Stenotrophomonas maltophilia bacteriophages capable of cross-taxonomic order infectivity

  2015cites this paper
• Single molecule real-time sequencing of Xanthomonas oryzae genomes reveals a dynamic structure and complex TAL (transcription activator-like) effector gene relationships

  2015cites this paper
• A PCR-BASED DETECTION OF BURKHOLDERIA PSEUDOMALLEI DIVERSITY USING MYOVIRIDAE PROPHAGE TYPING.

  2015cites this paper
• Burkholderia cepacia Complex Phage-Antibiotic Synergy (PAS): Antibiotics Stimulate Lytic Phage Activity

  2014cites this paper
• Bacteriophages of Pseudomonas aeruginosa: long-term prospects for use in phage therapy.

  2014cites this paper
• Aerosol phage therapy for in vivo Burkholderia cepacia complex respiratory infections

  2013cites this paper
• Identification and characterization of ϕH111-1

  2013cites this paper
• Respirable Bacteriophages for the Treatment of Bacterial Lung Infections

  2013cites this paper
• Genomic characterization of JG068, a novel virulent podovirus active against Burkholderia cenocepacia

  2013influential citation
• The Promise of Bacteriophage Therapy for Burkholderia cepacia Complex Respiratory Infections

  2012cites this paper
• Characterization of DC 1 , a Broad-Host-Range Bcep 22-Like Podovirus

  2012cites this paper
• Cangene gold medal award lecture - Genomic analysis and modification of Burkholderia cepacia complex bacteriophages.

  2012cites this paper
• Comparative analysis of two phenotypically-similar but genomically-distinct Burkholderia cenocepacia-specific bacteriophages

  2012influential citation
• Vergleichende Untersuchungen zur Wirkung verschiedener Liposomenformulierungen auf das humane und murine Komplementsystem

  2012cites this paper
• Genomes and Characterization of Phages Bcep22 and BcepIL02, Founders of a Novel Phage Type in Burkholderia cenocepacia

  2011cites this paper
• Characterization of DC1, a Broad-Host-Range Bcep22-Like Podovirus

  2011cites this paper
• This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon.

  2010cites this paper
• Genomic analysis and relatedness of P2-like phages of the Burkholderia cepacia complex

  2010cites this paper